Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 386 of 673

Advanced search

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Principal Financial Group Inc. Decreases Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries (TEVA) Raises Revenue Guidance, Is The 15% Undervaluation Still There?

simplywall.stOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Some More Notes On Pharmaceutical Tariffs

Seeking AlphaOriginal source

🌍Jul 30discoverynews.google.comTier 2 · Trade media

U.S. dependence on China is a national security risk

STATOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Interim heat mortality monitoring report, England: May and June 2026

Ad-hoc statistics report on the surveillance of mortality during the May and June 2026 heat episodes...

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Pre-release access lists: Tuberculosis in England national quarterly reports

Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis in England: na...

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Pre-release access list: Reports of cases of TB to UK enhanced tuberculosis surveillance systems 2000 to 2024

Lists of those receiving pre-release access to UK Health Security Agency Tuberculosis annual data

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Measles, mumps and rubella: lab-confirmed cases in England 2026

Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Referenc...

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Haemophilus influenzae: lab reports by age group and serotype

Laboratory reports on cases of Haemophilus influenzae in England.

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Tuberculosis in England: national quarterly reports

The latest quarterly reports of provisional data for tuberculosis (TB) notifications in England.

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Reports of cases of TB to UK enhanced tuberculosis surveillance systems: 2000 to 2024

Official statistics from the UK enhanced tuberculosis surveillance systems, annual report: 2000 to 2...

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Tuberculosis (TB): diagnosis, screening, management and data

Information on the diagnosis, screening, epidemiology and public health strategy for tuberculosis an...

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Pertussis immunisation in pregnancy: vaccine coverage (England)

Vaccine uptake data and commentary about the pertussis (whooping cough) vaccination programme for pr...

UK Health Security AgencyOriginal source

🇺🇰Jul 30Regulatorygov.ukTier 1 · Regulatory source

Reports of cases of TB to UK enhanced tuberculosis surveillance systems, 2000 to 2025

Official statistics from the UK enhanced tuberculosis surveillance systems, annual report: 2000 to 2...

UK Health Security AgencyOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Pune: FDA Suspends Licences of 21 Food Establishments Across Pune Division

lokmattimes.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Chong Kun Dang Bio Gains FDA Trial Approval

BusinesskoreaOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

MassChallenge Launches Breakthrough Bio to Catapult International Biotech and Medtech Start-ups in the U.S. Market

geneonline.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) Could Be 40% Overvalued As KB801 News Tests Its Price

finance.yahoo.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Profit Drops 9% in Fiscal Q1

marketscreener.comOriginal source

🇺🇰Jul 30Researchukri.orgTier 2 · Direct publisher

First UK patient given bespoke lung cancer therapy vaccine

Medical Research Council (UKRI)Original source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Fiscal Q1 Core Earnings, Revenue Rise

marketscreener.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited Reaffirms Earnings Guidance for the Fiscal Year 2026

marketscreener.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Pune: FDA Suspends Licences Of 21 Food Establishments, Seizes ₹50.65 Lakh Worth Of Suspected Adulterated

Free Press JournalOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

A Maternal GBS Vaccine Just Cleared Phase 1/2. Here’s What the Trial Design Tells Us About the Regulatory Gauntlet Ahead.

The Clinical Trial VanguardOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Does BioMarin (BMRN) Expanding Into ReNU Syndrome Refine Its Rare Disease Pipeline Strategy?

simplywall.stOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (4502) Earnings: Strong 1Q Beats Estimates with Net Income at 113.2 Billion Yen

SmartkarmaOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

'Double Shifts, Work Pressure': Maharashtra Food Safety Body Head Faces 'Staff Shortage' Complaint

NDTVOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Viking Therapeutics Advances VK2735 Oral Program Into Phase 3 Trials

The Clinical Trial VanguardOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Beijing Hanmi Profit Nearly Vanishes Amid Receivables Concerns

BusinesskoreaOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

GSK Strikes AI Deal With UK Biotech to Boost Early Pipeline

Bloomberg.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

FDA: Ban on Sale of Junk Food within 50 Meters of Schools; Major Decision by the Food and Drug Administration

Lokshahi English NewsOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

The Top 5 Analyst Questions From Thermo Fisher’s Q2 Earnings Call

TradingViewOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Seize the Golden Window for Biotech IPOs, Attovia Aims to Raise Up to $212.5 Million in Nasdaq Debut

NAI500Original source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Bombay High Court Seeks Inspection Details of Government Canteens Amid FDA Enforcement Drive

lawtrend.inOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

CSPC Hunan Jingfeng Pharmaceutical Co Ltd Class A Revenue Breakdown – SZSE:000908

TradingViewOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Conserving tropical forests could preserve billions of dollars in pharmaceutical value from undiscovered drugs

Zero Carbon AnalyticsOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Bombay HC asks Maharashtra govt. to give details of FDA inspections at State-run canteens, eating places

The HinduOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Daewoong's botulinum toxin Nabota enters Kuwait

The Korea HeraldOriginal source

🇨🇭Jul 30CDMObachem.comTier 2 · Direct publisher

Bachem confirms growth and expects a strong second half 2026

Bachem PeptidesOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Dasher Neuroscience Completes Patient Enrollment in Phase 2 Global Clinical Trial of Lead AI Drug Candidate YA-101 for Multiple System Atrophy (MSA)

Macau BusinessOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

The Lancet: Bloodstream-delivered cell therapy slows muscle decline in

Bioengineer.orgOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

BRVE IPO News - Cardiovascular diseases biotech Braveheart Bio sets terms for $300 million IPO

renaissancecapital.comOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments

Optometry AdvisorOriginal source

🇺🇸Jul 30Regulatoryfda.govTier 1 · Regulatory source

Convenience Kit Correction: Argon Medical Issues Correction for Convenience Kits Containing Spectra Medical Device Lidocaine Ampules

Argon Medical is correcting affected convenience kits by removing included Spectra Medical Devices L...

FDA MedWatchOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Honz Pharmaceutical Co., Ltd. Class A – SZSE:300086

TradingViewOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Families gather at state capitol to mark Prescribed Harm Awareness Day

WILXOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

ASCA2026: Last Chance to Get Early Bird Discount

ISAAA.orgOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

12 Funding Rounds That Show Where APAC Biotech Capital Is Going

BioPharma APACOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Dimerix (ASX:DXB) Builds Pipeline Momentum With Phase 3 Progress and New Commercial Partnership

KalkineOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Alterity Therapeutics (ASX:ATH) Gains Ground as FDA Clears Pathway Toward ATH434 Phase 3 Trial

KalkineOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Precision Trading with Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Risk Zones

Stock Traders DailyOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Actinogen Medical keeps pivotal Alzheimer’s trial on track for November readout

Proactive financial newsOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

K-CAB eyes FDA approval after dominating home market, expanding abroad

헤럴드경제Original source

🌍Jul 30Researchindicalab.comTier 2 · Direct publisher

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development

Indica LabsOriginal source

🌍Jul 30discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) Is Up 7.9% After S&P 400 Move And New KB801 Patent Filing Update

finance.yahoo.comOriginal source

🌍Jul 30Regulatoryfifarma.orgTier 1 · Regulatory source

FIFARMA se une à Aliança para a Eliminação do HIV nas Américas

FIFARMA NewsOriginal source

🌍Jul 30Researchindicalab.comTier 2 · Direct publisher

HALO® ADC Target Scoring Module Features and Functionalities

Indica LabsOriginal source

🇺🇸Jul 30Regulatorysec.govTier 1 · Regulatory source

Regeneron filed Form 10-Q

SEC EDGAROriginal source

🇺🇸Jul 30Regulatorysec.govTier 1 · Regulatory source

Regeneron filed Form 8-K

SEC EDGAROriginal source

🇺🇸Jul 30Regulatorysec.govTier 1 · Regulatory source

BioNTech filed Form 20-F/A

SEC EDGAROriginal source